News
Featured News
Flexibility, creativity, and dedication to make better therapeutics are at the heart of what we do. Read more on recent updates and highlights around our contract drug manufacturing activities.
BIOVECTRA and Revolution Biomanufacturing Partner to Deliver Integrated mRNA Design and GMP Production Services — Partnership Combines Sequence Design Expertise with End-to-End GMP Manufacturing to Streamline mRNA Development and Scale-up
November 6, 2025
BIOVECTRA Inc. Invests $1.5M in Large-Scale Synthetic Reactor Replacements and Analytical Development Capabilities
BIOVECTRA Inc. Invests $1.5M in Large-Scale Synthetic Reactor Replacements and Analytical Development Capabilities BIOVECTRA Inc., a global Contract Development and Manufacturing Organization (CDMO), today announced […]
BIOVECTRA Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund
BIOVECTRA Inc. announces a $144.6 million expansion project, including a $37.5 million contribution through the Government of Canada’s Strategic Innovation Fund — Prime Minister Justin […]
BIOVECTRA wins BIOTECanada’s Gold Leaf Award for Company of the Year!
CANADIAN BIOTECH INDUSTRY RECOGNIZES TOP PERFORMERS DURING GLOBAL BIOTECH WEEK September 26, 2018 [OTTAWA] – BIOTECanada is pleased to announce the 2018 winners of the […]
BIOVECTRA and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins
BIOVECTRA and TUBE Biopharmaceuticals Sign Exclusive License for Microbial Fermentation Technology to Manufacture Tubulysins 16/07/18 – CHARLOTTETOWN, Prince Edward Island, Canada – Today, BIOVECTRA Inc., […]
Windsor Expansion Helps BIOVECTRA Meet Global Market Demand
Windsor Expansion Helps BIOVECTRA Meet Global Market Demand Extensive facility renovation, new equipment, assists life sciences firm in creating jobs, growing regional economy April 12, […]
BIOVECTRA and Keryx Biopharmaceuticals Enter Agreement for Ferric Citrate Production Expansion
BioVectra Inc., an innovative global contract development and manufacturing organization (CDMO), today announced a long-term supply agreement with Keryx Biopharmaceuticals, […]
<a class="btn btn-secondary understrap-read-more-link"
